Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A phase I–II study of rituximab, ifosfamide, mitoxantrone andetoposide (R-IME) for B cell non-Hodgkin’s lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT)
PaperCitations, authors & open-access status
A phase I–II study of rituximab, ifosfamide, mitoxantrone andetoposide (R-IME) for B cell non-Hodgkin’s lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 13 citations, 2003 year and closed oa status.
13
Citations
2003
Year
closed
OA Status